{"database": "openregs", "table": "documents", "rows": [["FDA-2003-P-0346-0002", "FDA", "FDA-2003-P-0346", "Proposed Rule re Microbiology Devices; Reclassification of Hepatitis A Virus (HAV) Serological Assays (IgM Antibody, IgG Antibody and Total Antibodies [IgM and IgG])", "Proposed Rule", "NPR-Notice of Proposed Rule-Making", "2004-09-30T04:00:00Z", 2004, 9, "2004-09-29T04:00:00Z", "2004-12-30T04:59:59Z", "2024-11-25T16:34:43Z", "69FR58371", 0, 0, "0900006480496e02"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2003-P-0346-0002"], "units": {}, "query_ms": 0.9322840487584472, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}